China Bridge Invests $45 Billion in iCarbonX; Plans $1.5 Billion Precision Medicine Fund

China Bridge Capital, a Beijing financial services firm, invested $45 million in iCarbonX, the big data/AI healthcare start-up that raised $155 million in a Series A at a $1 billion valuation earlier this year. iCarbonX was founded by Jun Wang, formerly CEO of BGI, China's giant gene sequencing company. China Bridge also plans to raise $1.5 billion for an investment fund that acquires precision healthcare assets, a focus area for iCarbonX.